BioGaia Signs Exclusive Distribution Agreement for Its Probiotic Drops and Tablets in Pakistan
Published: Oct 12, 2012
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Today BioGaia (STO:BIOG) has signed an agreement with Ferozsons Laboratories Limited, for the exclusive rights to sell BioGaia’s probiotic drops and tablets in Pakistan. The products will be sold under the BioGaia brand and launch is planned to 2013. Ferozsons Laboratories Limited (http://www.ferozsons-labs.com/) is one of Pakistan's leading pharmaceutical companies. Several of the company’s brands are market leaders in the fields of gastroenterology, cardiology and oncology. Ferozsons Laboratories Limited is focused on medical marketing and has a large medical field force. The company has been listed on Pakistan’s three Stock Exchanges since 1960.